We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Stem Cells Predict Disease and Drug Toxicity

By Biotechdaily staff writers
Posted on 24 Dec 2007
Scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease. More...


All-purpose stem cells elicited and identified the chemical signals secreted by the stem cells when exposed to a drug known to cause autism. The research shows that stem cells have an immediate clinical application as they generate chemicals, biomarkers that can be used to predict the onset of disease, much like cholesterol or sugar in the blood can be used to forecast heart disease or diabetes.

In a new study, a team led by University of Wisconsin-Madison, (UW-Madison; Madison, WI, USA) biologist Prof. Gabriela Cezar measured the response of undifferentiated stem cells as well as precursor neural cells to the drug valproate, which is known to cause autism in the offspring of a small percentage of users. The drug is used to treat epilepsy, bipolar disease, and migraine headaches. "We [are] measuring active metabolites produced by the cells in response to an insult,” explained Dr. Cezar, a professor of animal science. "These are de facto signatures of what is happening in response to a drug or a disease state.”

Cells of all kinds use small-molecule chemicals as a way to communicate with other cells. Precise communication between cells is essential for normal development and the health of an organism. Such chemicals can be detected in blood, suggesting that it may be possible to devise simple tests that can provide disease diagnosis before birth or shortly after. The ability to tune in to the chemical chatter of stem cells may become a promising new window to helping scientists figure out, at the most fundamental level, what goes wrong to cause things such as birth defects and miscarriage.

In addition, the study shows how human embryonic stem cells and early precursor cells can be used to screen drugs for potentially harmful effects. Drug discovery and testing had been predicted to be one of the first technologies to emerge from embryonic stem cells.

The study was reported in the December 2007 journal Stem Cells and Development.


Related Links:
University of Wisconsin-Madison

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automated Urinalysis Solution
UN-9000
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.